Robert H.I. Andtbacka
- Oncology top 0.5%
- Immunology top 1%
- Molecular Biology top 5%
- Genetics top 1%
- Epidemiology top 5%
- Co-authors
- Lisa ChenIgor PuzanovFrances A. CollichioKevin GorskiHoward L. KaufmanMohammed MilhemJennifer GansertF. Stephen Hodi
- Topics
- CAR-T cell therapy research (33 papers)Virus-based gene therapy research (22 papers)Immunotherapy and Immune Responses (21 papers)
- Cited by
- OncologyImmunologyGenetics
- Journals
- CellJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Robert H.I. Andtbacka
87 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 3.4k
- Immunology 1.8k
- Molecular Biology 1.8k
- Genetics 1.6k
- Epidemiology 547
Countries citing papers authored by Robert H.I. Andtbacka
This map shows the geographic impact of Robert H.I. Andtbacka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H.I. Andtbacka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H.I. Andtbacka more than expected).
Fields of papers citing papers by Robert H.I. Andtbacka
This network shows the impact of papers produced by Robert H.I. Andtbacka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H.I. Andtbacka. The network helps show where Robert H.I. Andtbacka may publish in the future.
Co-authorship network of co-authors of Robert H.I. Andtbacka
This figure shows the co-authorship network connecting the top 25 collaborators of Robert H.I. Andtbacka. A scholar is included among the top collaborators of Robert H.I. Andtbacka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H.I. Andtbacka. Robert H.I. Andtbacka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 38 | |
| 6 | 15 | |
| 7 | Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomasbreakdown → | 240 |
| 8 | 39 | |
| 9 | 47 | |
| 10 | 3 | |
| 11 | 0 | |
| 12 | 3 | |
| 13 | Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanomabreakdown → | 435 |
| 14 | 3 | |
| 15 | 15 | |
| 16 | 22 | |
| 17 | 17 | |
| 18 | 27 | |
| 19 | 204 | |
| 20 | 13 |
About Robert H.I. Andtbacka
Robert H.I. Andtbacka is a scholar working on Oncology, Biotechnology and Immunology, having authored 92 papers that have together received 5.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (33 papers), Virus-based gene therapy research (22 papers) and Immunotherapy and Immune Responses (21 papers). The work is most often cited by research in Oncology (3.4k citations), Immunology (1.8k citations) and Genetics (1.6k citations). Robert H.I. Andtbacka has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Lisa Chen, Igor Puzanov, Frances A. Collichio, Kevin Gorski, Howard L. Kaufman, Mohammed Milhem, Jennifer Gansert, F. Stephen Hodi, Merrick I. Ross and Russell S. Richardson. Their work appears in journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.